WO2001075075A3 - Human tyrosine phosphatase-like enzymes - Google Patents

Human tyrosine phosphatase-like enzymes Download PDF

Info

Publication number
WO2001075075A3
WO2001075075A3 PCT/EP2001/003395 EP0103395W WO0175075A3 WO 2001075075 A3 WO2001075075 A3 WO 2001075075A3 EP 0103395 W EP0103395 W EP 0103395W WO 0175075 A3 WO0175075 A3 WO 0175075A3
Authority
WO
WIPO (PCT)
Prior art keywords
tyrosine phosphatase
enzymes
human tyrosine
human
carcinomas
Prior art date
Application number
PCT/EP2001/003395
Other languages
French (fr)
Other versions
WO2001075075A2 (en
Inventor
Yonghong Xiao
Original Assignee
Bayer Ag
Yonghong Xiao
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag, Yonghong Xiao filed Critical Bayer Ag
Priority to AU2001252233A priority Critical patent/AU2001252233A1/en
Publication of WO2001075075A2 publication Critical patent/WO2001075075A2/en
Publication of WO2001075075A3 publication Critical patent/WO2001075075A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Human tyrosine phosphatase-like enzyme can be regulated to treat or prevent diseases such as rheumatoid arthritis and osteoarthritis and carcinomas of the intestine, bladder, prostate, breast, stomach, and brain.
PCT/EP2001/003395 2000-03-27 2001-03-26 Human tyrosine phosphatase-like enzymes WO2001075075A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001252233A AU2001252233A1 (en) 2000-03-27 2001-03-26 Human tyrosine phosphatase-like enzymes

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US19231500P 2000-03-27 2000-03-27
US60/192,315 2000-03-27
US21073500P 2000-06-12 2000-06-12
US60/210,735 2000-06-12

Publications (2)

Publication Number Publication Date
WO2001075075A2 WO2001075075A2 (en) 2001-10-11
WO2001075075A3 true WO2001075075A3 (en) 2003-05-30

Family

ID=26887969

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/003395 WO2001075075A2 (en) 2000-03-27 2001-03-26 Human tyrosine phosphatase-like enzymes

Country Status (2)

Country Link
AU (1) AU2001252233A1 (en)
WO (1) WO2001075075A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003033688A1 (en) * 2001-10-16 2003-04-24 Bayer Healthcare Ag Regulation of human receptor tyrosine phosphatase

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998040486A2 (en) * 1997-03-14 1998-09-17 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO2001075067A2 (en) * 2000-03-31 2001-10-11 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2001096546A2 (en) * 2000-06-16 2001-12-20 Incyte Genomics, Inc. Protein phosphatases

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998040486A2 (en) * 1997-03-14 1998-09-17 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO2001075067A2 (en) * 2000-03-31 2001-10-11 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2001096546A2 (en) * 2000-06-16 2001-12-20 Incyte Genomics, Inc. Protein phosphatases

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 12 January 1999 (1999-01-12), "DNA from clone gm243_1 which encodes a secreted protein.", XP002211444, retrieved from EBI Database accession no. AAV63177 *
DATABASE EMBL [online] 13 February 2002 (2002-02-13), "DNA encoding novel human diagnostic protein #23514.", XP002211449, retrieved from EBI Database accession no. AAS87710 *
DATABASE EMBL [online] 5 June 1997 (1997-06-05), HILLIER L. ET AL.: "zw93c02.r1 Soares_ total_fetus_Nb2HF8_9w Homo sapiens cDNA clone.", XP002211447, retrieved from EBI Database accession no. AA447242 *
DATABASE EMBL [online] 6 February 2002 (2002-02-06), "Sequence 15 from Patent WO0196546.", XP002211451, retrieved from EBI Database accession no. AX354537 *
DIAMOND R H ET AL: "PRL-1, A UNIQUE NUCLEAR PROTEIN TYROSINE PHOSPHATASE, AFFECTS CELL GROWTH", MOLECULAR AND CELLULAR BIOLOGY, WASHINGTON, DC, US, vol. 14, no. 6, 1 June 1994 (1994-06-01), pages 3752 - 3762, XP000196604, ISSN: 0270-7306 *
FAUMAN E B ET AL: "Structure and function of the protein tyrosine phosphatases", TIBS TRENDS IN BIOCHEMICAL SCIENCES, ELSEVIER PUBLICATION, CAMBRIDGE, EN, vol. 21, no. 11, 1 November 1996 (1996-11-01), pages 413 - 417, XP004071016, ISSN: 0968-0004 *
MONTAGNA M ET AL: "A 100-KB PHYSICAL AND TRANSCRIPTIONAL MAP AROUND THE EDH17B2 GENE: IDENTIFICATION OF THREE NOVEL GENES AND A PSEUDOGENE OF A HUMAN HOMOLOGUE OF THE RAT PRL-1 TYROSINE PHOSPHATASE", HUMAN GENETICS, BERLIN, DE, vol. 96, no. 4, 1 October 1995 (1995-10-01), pages 532 - 538, XP000196605 *

Also Published As

Publication number Publication date
AU2001252233A1 (en) 2001-10-15
WO2001075075A2 (en) 2001-10-11

Similar Documents

Publication Publication Date Title
WO2002060955A3 (en) Modified antibodies and methods of use
WO2003032916A3 (en) Organosulfur inhibitors of tyrosine phosphatases
GT199900013A (en) TREATMENT OF FEMALE SEXUAL DYSFUNCTION.
EP1955700A3 (en) Therapeutic treatment of androgen receptor driven conditions
EP1691760A4 (en) Devices systems, and methods to fixate tissue within the regions of the body, such as the pharyngeal conduit
AU1926001A (en) Novel human protein kinases and protein kinase-like enzymes
WO2002016429A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2003024392A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO1999058674A3 (en) Method of inhibiting osteoclast activity
WO2006027521A3 (en) Method of obtaining a firming active principle and active principle thus obtained
WO2001037819A3 (en) Use of indirubine derivatives for making medicines
WO2002016581A3 (en) Compositions and methods for the diagnosis and treatment of tumor
AUPQ744700A0 (en) A method of treatment and agents useful for same
WO1999053086A8 (en) Small molecule anticancer compounds and related production process
WO2002016602A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004031367A3 (en) Uses of human zven proteins and polynucleotides
WO2001075075A3 (en) Human tyrosine phosphatase-like enzymes
AU2001234544A1 (en) Novel human protein kinases and protein kinase-like enzymes
WO2003056897A3 (en) Highly phosphorylated acid beta-glucocerebrosidase and methods of treating gaucher's disease
WO1999016406A3 (en) Therapeutic method
AU9352401A (en) Production process and composition of an enzymatic preparation, and its use for the treatment of domestic and industrial effluents of high fat, protein and/or carbohydrate content
ZA200203166B (en) Treatment of cancer.
AU2002214950A1 (en) Determination of the ability of patients to respond to tumour treatment
WO1998024482A3 (en) Use of endothelin conjugates in therapy, new endothelin conjugates, substances containing them, and processes for producing them
MXPA00012560A (en) Use of interleukin-11 to treat gastrointestinal disorders.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP